Piece from the Guardian pointing to an investigation by the competition authority into price fixing within the pharmaceutical industry.
Actavis charged NHS 80% more for hydrocortisone tablets after incentivising rival Concordia not to launch its own version, watchdog claims
Source: UK pharma firms accused of illegal deals to hike price of life-saving drug
The Centre for Health and the Public Interest (CHPI) has recently published a report on private finance initiatives (PFI). The report, intended for policy-makers, outlines five options for coping with PFI and its lasting effects, […]
Highlighting findings from the Royal College of Radiologists, ‘Clinical Radiology UK Workforce Census 2017 Report’, a recent BMJ news article calls attention to the rising expenditure by the NHS on outsourced radiology patient scans. With […]
The UK government will offer up to £86 million in funding to UK firms that work to develop ‘medical breakthroughs.’ Funds will go to small and medium sized enterprises (SMEs) that wish to develop and […]
Copyright: Corporate Welfare Watch 2017